Applications of Endocrinology/Hormones in Metabolic Regulation, Reproductive Function, and Disease Research
Applications of Endocrinology/Hormones in Metabolic Regulation, Reproductive Function, and Disease Research
The endocrine system maintains body homeostasis through hormone secretion, target organ responses, and feedback regulation. Hormones regulate glucose and lipid metabolism, growth and development, reproductive function, stress responses, water and electrolyte balance, bone metabolism, and energy homeostasis. They are important research objects in diabetes, thyroid diseases, reproductive endocrine disorders, adrenal diseases, and hormone-dependent tumors.
Keywords: endocrinology; hormones; insulin; thyroid hormone; steroid hormone; sex hormone; HPA axis; GPCR
1 Hormone Types and Functional Characteristics
1.1 Peptide and Protein Hormones
Peptide and protein hormones are usually secreted after precursor protein processing. They are highly water-soluble and mainly act through cell membrane receptors. Insulin, glucagon, ACTH, TSH, LH, FSH, GH, PRL, PTH, GLP-1, GIP, leptin, and adiponectin all belong to this category. These hormones often activate signaling branches such as cAMP, Ca²⁺, PI3K/AKT, MAPK, and STAT through GPCRs, receptor tyrosine kinases, or JAK/STAT-related receptors.
1.2 Steroid Hormones
Steroid hormones are derived from cholesterol and include glucocorticoids, mineralocorticoids, estrogens, progestogens, and androgens. These hormones are highly lipid-soluble and can enter cells to bind nuclear receptors or cytoplasmic receptors, thereby regulating target gene transcription. They can also produce rapid effects through non-genomic mechanisms. Steroid hormone research should focus on total hormone, free hormone, binding proteins, metabolic enzymes, and receptor expression.
1.3 Amino Acid-Derived Hormones
Thyroid hormones, catecholamines, and melatonin are amino acid-derived hormones. T3/T4 mainly regulate basal metabolism and development through thyroid hormone receptors. Epinephrine, norepinephrine, and dopamine participate in stress, cardiovascular, and neuroendocrine responses through adrenergic receptors or dopamine receptors. Melatonin is associated with circadian rhythm, sleep, and oxidative stress regulation.
1.4 Vitamin D and Local Hormone-Like Molecules
Vitamin D is metabolized by the liver and kidney to form active calcitriol, which regulates calcium-phosphate homeostasis, bone metabolism, and immune function through the vitamin D receptor (VDR). Lipid-derived molecules such as prostaglandins, leukotrienes, and endocannabinoids have local hormone-like effects and often intersect with inflammation, vascular responses, and metabolic regulation.
Table 1 Hormone Types and Functional Characteristics
Hormone Type | Representative Members | Main Receptor Types | Main Actions | Common Research Directions |
Peptide/protein hormones | Insulin, glucagon, TSH, LH, FSH, GH, GLP-1, PTH | GPCRs, RTKs, JAK/STAT-related receptors | Rapid secretion and membrane receptor-mediated effects | Glucose metabolism, reproductive axis, pituitary function, calcium-phosphate metabolism |
Steroid hormones | Cortisol, aldosterone, estradiol, progesterone, testosterone | Nuclear receptors, some membrane-associated receptors | Strong transcriptional regulation and tissue specificity | Stress, reproduction, inflammation, hormone-dependent tumors |
Amino acid-derived hormones | T3, T4, epinephrine, norepinephrine, dopamine, melatonin | Nuclear receptors, GPCRs | Metabolism, stress, rhythm regulation | Thyroid function, sympathetic-adrenal system, circadian rhythm |
Vitamin D axis-related molecules | Cholecalciferol, calcitriol | VDR | Calcium-phosphate homeostasis, bone metabolism, immune regulation | Osteoporosis, chronic kidney disease, immunometabolism |
2 Major Endocrine Axes and Regulatory Networks
2.1 Hypothalamic-Pituitary-Thyroid Axis
The hypothalamus secretes TRH, which promotes pituitary release of TSH. TSH acts on the thyroid gland and promotes the synthesis and release of T3/T4. Increased T3/T4 can inhibit TRH and TSH through negative feedback. This axis mainly regulates basal metabolism, body temperature, neural development, cardiovascular function, and energy expenditure.
2.2 Hypothalamic-Pituitary-Adrenal Axis
The HPA axis consists of CRH, ACTH, and cortisol, and is an important system for stress responses, glucose metabolism, and inflammatory regulation. Cortisol has a clear circadian rhythm, so sampling time must be considered during detection and interpretation. Aldosterone mainly participates in water and electrolyte balance, blood pressure regulation, and cardiac-renal remodeling.
2.3 Hypothalamic-Pituitary-Gonadal Axis
The HPG axis consists of GnRH, LH, FSH, and gonadal hormones. It regulates follicular development, ovulation, luteal function, spermatogenesis, pregnancy maintenance, and development of secondary sexual characteristics. Estrogen, progesterone, testosterone, AMH, inhibin, and prolactin are commonly used to evaluate reproductive endocrine function.
2.4 Islet-Incretin-Adipokine Network
Insulin, glucagon, GLP-1, GIP, leptin, adiponectin, and FGF21 jointly regulate blood glucose, lipid metabolism, appetite, energy expenditure, and pancreatic β-cell function. Research on diabetes, obesity, fatty liver, and metabolic syndrome usually requires simultaneous analysis of islet function, insulin sensitivity, and adipose tissue endocrine status.
2.5 Calcium-Phosphate Metabolism Axis
PTH, vitamin D, calcitonin, and FGF23 jointly regulate blood calcium, blood phosphorus, bone remodeling, and renal reabsorption. This axis is closely associated with osteoporosis, chronic kidney disease-mineral and bone disorder, parathyroid dysfunction, and vitamin D deficiency.
Table 2 Major Endocrine Axes and Detection Indicators
Endocrine Axis | Representative Hormones | Main Functions | Common Detection |
HPT axis | TRH, TSH, T3, T4 | Basal metabolism, neural development, cardiovascular function | TSH, FT4, FT3, TPOAb, TgAb, TRAb |
HPA axis | CRH, ACTH, cortisol, DHEA-S | Stress, inflammation, glucose metabolism, and immune regulation | ACTH, cortisol, DHEA-S |
HPG axis | GnRH, LH, FSH, E2, P4, testosterone | Reproduction, gonadal function, and pubertal development | LH, FSH, E2, P4, Testosterone, AMH |
Islet metabolic axis | Insulin, glucagon, GLP-1, GIP | Glucose and lipid metabolism, islet function, and energy homeostasis | Insulin, C-peptide, blood glucose, GLP-1, GIP |
Adipokine network | Leptin, adiponectin, resistin, FGF21 | Adipose tissue endocrinology, inflammation, and insulin sensitivity | Leptin, adiponectin, LAR, FGF21 |
Calcium-phosphate metabolism axis | PTH, vitamin D, calcitonin, FGF23 | Calcium-phosphate homeostasis and bone metabolism | PTH, 25(OH)D, blood calcium, blood phosphorus, FGF23 |
3 Hormone Receptors and Downstream Signaling
3.1 GPCR-Mediated Hormone Signaling
ACTH, TSH, LH, FSH, GLP-1, glucagon, PTH, catecholamines, and other hormones can act through GPCRs. GPCRs regulate branches such as cAMP/PKA, Ca²⁺/PKC, MAPK, and RhoA/ROCK through G proteins including Gs, Gi/o, Gq/11, and G12/13, thereby affecting secretion, metabolism, contraction, and cellular function.
3.2 RTK and PI3K/AKT Signaling
Insulin and IGF-1 mainly activate PI3K/AKT and MAPK branches through receptor tyrosine kinases. After insulin stimulation, p-IR, p-IRS, p-AKT, GLUT4 translocation, and glucose uptake are commonly detected to evaluate insulin sensitivity and metabolic response.
3.3 JAK/STAT-Related Hormone Signaling
GH, PRL, leptin, and related hormones regulate target gene expression through JAK/STAT-related mechanisms. GH often affects growth and metabolism through JAK2/STAT5, while leptin often affects appetite, energy expenditure, and inflammatory status through JAK2/STAT3.
3.4 Nuclear Receptor-Mediated Transcriptional Regulation
Estrogens, progesterone, androgens, glucocorticoids, mineralocorticoids, thyroid hormones, and vitamin D mainly regulate transcription through nuclear receptors. Nuclear receptor effects depend not only on hormone concentration, but also on receptor expression, coactivators, corepressors, chromatin state, and tissue context.
Table 3 Hormone Receptor Types and Research Indicators
Receptor Type | Representative Hormones | Main Signaling | Common Detection |
GPCR | ACTH, TSH, LH, FSH, GLP-1, PTH, catecholamines | cAMP/PKA, Ca²⁺/PKC, MAPK | cAMP, p-CREB, Ca²⁺ imaging, p-ERK |
RTK | Insulin, IGF-1 | PI3K/AKT, MAPK | p-IR, p-IRS, p-AKT, GLUT4 |
JAK/STAT-related receptors | GH, PRL, leptin | JAK2/STAT3, JAK2/STAT5 | p-STAT3, p-STAT5, SOCS-related molecules |
Nuclear receptors | Estrogens, progesterone, androgens, glucocorticoids, mineralocorticoids, thyroid hormones, and vitamin D | Transcriptional regulation, chromatin remodeling | Receptor nuclear localization, target genes, reporter genes |
Membrane-associated steroid receptors | Some estrogens, progestogens, and glucocorticoids | MAPK, PI3K, Ca²⁺ | Rapid phosphorylation, Ca²⁺ changes, membrane receptor expression |
4 Endocrine Diseases and Research Focuses
4.1 Diabetes and Metabolic Syndrome
Research on diabetes and metabolic syndrome should focus on pancreatic β-cell function, insulin resistance, hepatic glucose output, adipose tissue inflammation, and incretin function. Insulin, C-peptide, glucagon, GLP-1, GIP, leptin, and adiponectin are commonly used indicators. Increased insulin can suggest compensatory insulin resistance, but if accompanied by decreased C-peptide and hyperglycemia, it may reflect insufficient β-cell secretory capacity.
4.2 Thyroid Diseases
Thyroid diseases include hyperthyroidism, hypothyroidism, autoimmune thyroiditis, and thyroid nodule-related abnormalities. TSH, FT4, FT3, and thyroid autoantibodies are the core detection panel. Elevated TSH with decreased FT4 supports primary hypothyroidism, while decreased TSH with elevated FT4/FT3 supports hyperthyroidism. If TSH does not match peripheral hormones, pituitary factors, drug effects, or assay interference should be considered.
4.3 Reproductive Endocrine Disorders
Reproductive endocrine disorders involve polycystic ovary syndrome, decreased ovarian reserve, male hypogonadism, infertility, and abnormal pubertal development. Female sex hormone testing should specify the menstrual cycle stage. Male testosterone testing usually prioritizes morning samples and should be interpreted together with SHBG and free testosterone.
4.4 Adrenal Diseases and Stress Abnormalities
Adrenal diseases include Cushing’s syndrome, adrenal insufficiency, primary aldosteronism, and pheochromocytoma-related abnormalities. ACTH, cortisol, aldosterone, renin, and catecholamine-related indicators are strongly affected by stress, body position, medications, and sampling time, so interpretation should be combined with dynamic tests or repeated sampling.
4.5 Bone Metabolism and Calcium-Phosphate Homeostasis Abnormalities
Osteoporosis, chronic kidney disease-mineral and bone disorder, and parathyroid diseases are closely associated with PTH, vitamin D, calcitonin, FGF23, sex hormones, and thyroid hormones. Bone metabolism research should integrate blood calcium, blood phosphorus, 25(OH)D, PTH, and bone turnover markers.
Table 4 Endocrine Diseases and Common Hormone Indicators
Disease Direction | Key Hormones | Main Mechanism | Common Detection |
Diabetes and insulin resistance | Insulin, C-peptide, glucagon, GLP-1, adiponectin, leptin | Pancreatic β-cell function, insulin sensitivity, adipose tissue function | Blood glucose, insulin, C-peptide, HbA1c, HOMA-IR |
Thyroid diseases | TSH, T3, T4, thyroid antibodies | HPT axis feedback and autoimmunity | TSH, FT4, FT3, TPOAb, TRAb |
Reproductive endocrine disorders | LH, FSH, E2, P4, Testosterone, AMH | HPG axis abnormalities and gonadal function changes | LH, FSH, sex hormones, AMH, PRL |
Adrenal diseases | ACTH, cortisol, aldosterone, catecholamines | Stress response, mineralocorticoids, and sympathetic-adrenal system abnormalities | ACTH, cortisol, ARR, urine/saliva indicators |
Bone metabolism abnormalities | PTH, vitamin D, calcitonin, FGF23 | Calcium-phosphate homeostasis, bone remodeling, and renal regulation | PTH, 25(OH)D, blood calcium, blood phosphorus, bone turnover markers |
Obesity and energy metabolism abnormalities | Leptin, adiponectin, ghrelin, FGF21 | Appetite, adipose tissue function, energy expenditure | Leptin, adiponectin, LAR, FGF21, blood lipids |
5 Representative Products Related to Endocrinology and Hormone Research
Research Module | Representative Product | CAS No. | Mechanism or Detection Positioning | Applicable Research |
Insulin signaling research | Human insulin | Insulin receptor agonist that activates the PI3K/AKT pathway | GLUT4 translocation, p-AKT, glucose uptake, and insulin sensitivity research | |
Glucagon signaling research | Glucagon | Glucagon receptor ligand | Hepatic glycogenolysis, gluconeogenesis, cAMP signaling, and blood glucose regulation research | |
Diabetes model construction | Streptozotocin | Pancreatic β-cell damaging agent | Type 1 diabetes models, islet injury, and hypoglycemic drug evaluation | |
Insulin resistance model | Palmitic acid | Saturated fatty acid that induces lipotoxicity and insulin resistance | Insulin resistance models in hepatocytes, adipocytes, and muscle cells | |
Metabolic stress research | Metformin hydrochloride | AMPK-related metabolic regulatory drug | Diabetes, AMPK, autophagy, hepatic glucose output, and insulin sensitivity research | |
Thyroid hormone research | L-Thyroxine (T4) | Thyroid hormone receptor ligand | Basal metabolism, thyroid function, development, and energy expenditure research | |
Thyroid hormone research | Triiodothyronine (T3) | Active thyroid hormone | Thyroid hormone receptor signaling, metabolic regulation, and target gene expression research | |
Glucocorticoid research | Cortisol | Glucocorticoid receptor ligand | HPA axis, stress, anti-inflammatory responses, and glucose metabolism research | |
Glucocorticoid intervention | Dexamethasone | Glucocorticoid receptor agonist | Anti-inflammatory responses, adipogenic/osteogenic differentiation, insulin resistance, and stress model research | |
Mineralocorticoid research | Aldosterone | Mineralocorticoid receptor ligand | Water-electrolyte balance, blood pressure regulation, renal reabsorption, and cardiovascular remodeling research | |
Sex hormone research | 17β-Estradiol | Estrogen receptor ligand | ERα/ERβ signaling, bone metabolism, reproductive endocrinology, and breast cancer research | |
Sex hormone research | Estrone | Estrogenic molecule | Estrogen metabolism, menopause-related endocrinology, and hormone-dependent disease research | |
Sex hormone research | Progesterone | Progesterone receptor ligand | Endometrium, luteal function, pregnancy maintenance, and PR signaling research | |
Adrenal androgen research | Dehydroepiandrosterone | Adrenal-derived androgen precursor | Adrenal function, sex hormone synthesis, and aging-related endocrine research | |
Catecholamine research | Dopamine hydrochloride | Dopamine receptor ligand | Neuroendocrinology, stress responses, and catecholamine signaling research | |
Catecholamine research | Norepinephrine bitartrate | α/β-adrenergic receptor ligand | Sympathetic-adrenal system, vascular responses, and stress model research | |
Catecholamine research | Epinephrine bitartrate | α/β-adrenergic receptor agonist | Cardiovascular responses, stress hormone signaling, and metabolic mobilization research | |
Circadian rhythm hormone research | Melatonin | Pineal gland-derived rhythmic hormone | Sleep rhythm, oxidative stress, neuroendocrinology, and light-cycle rhythm research | |
Vitamin D axis research | Cholecalciferol | Vitamin D3 precursor | Vitamin D metabolism, calcium-phosphate homeostasis, and bone metabolism research | |
Vitamin D axis research | Calcitriol | Active vitamin D | VDR signaling, calcium-phosphate metabolism, bone formation, and immune regulation research | |
Estrogen receptor regulation | Tamoxifen citrate | Selective estrogen receptor modulator | ER-positive breast cancer, estrogen-dependent proliferation, and endocrine therapy research | |
Estrogen receptor regulation | Fulvestrant | Estrogen receptor degrader/antagonist | ER signaling blockade, breast cancer resistance, and nuclear receptor pharmacodynamics research | |
Androgen receptor regulation | Flutamide | Androgen receptor antagonist | AR signaling, prostate cancer, and androgen-dependent growth research | |
Androgen receptor regulation | Bicalutamide | Androgen receptor antagonist | AR pathway inhibition, prostate cancer models, and resistance mechanism research | |
Progesterone/glucocorticoid receptor regulation | Mifepristone | Progesterone receptor and glucocorticoid receptor antagonist | PR/GR signaling, reproductive endocrinology, and cortisol-related disease research | |
Mineralocorticoid receptor regulation | Spironolactone | Mineralocorticoid receptor antagonist | Aldosterone signaling, hypertension, cardiac-renal remodeling, and water-electrolyte metabolism research | |
Mineralocorticoid receptor regulation | Eplerenone | Selective mineralocorticoid receptor antagonist | MR signaling, cardiovascular remodeling, and renal protection research | |
GPCR hormone signaling research | Forskolin | Adenylyl cyclase activator that increases cAMP levels | Positive control for Gs-cAMP pathways such as ACTH, TSH, LH/FSH, and GLP-1 | |
cAMP signaling research | IBMX | Nonselective PDE inhibitor that enhances cAMP signaling | GPCR hormone signaling, cAMP accumulation, and secretion function research | |
Insulin/IGF signaling research | LY294002 | PI3K inhibitor | Insulin-PI3K/AKT pathway, GLUT4 translocation, and cell survival research | |
PI3K/AKT signaling research | Wortmannin | PI3K inhibitor | Dependency validation for insulin, IGF-1, adipokines, and growth signaling | |
mTOR metabolic signaling research | Rapamycin | mTOR inhibitor | Insulin nutrient signaling, protein synthesis, lipid metabolism, and autophagy research | |
Adrenergic signaling research | Isoproterenol hydrochloride | β-adrenergic receptor agonist | cAMP/PKA signaling, lipolysis, cardiovascular responses, and stress responses | |
Adrenergic signaling research | Propranolol hydrochloride | β-adrenergic receptor antagonist | Sympathetic endocrine signaling, cardiovascular responses, and receptor specificity validation |
6 Common Questions in Endocrinology and Hormone Research
6.1 Does an Increased Hormone Level Always Indicate Endocrine Hyperfunction?
Not necessarily. Increased hormone levels may result from primary hypersecretion, but may also be caused by receptor resistance, weakened negative feedback, changes in binding proteins, drug effects, or reduced clearance. Endocrine hyperfunction should be evaluated together with upstream and downstream hormones as well as target organ function.
6.2 Is a Single Hormone Measurement Sufficient to Determine the Disease Mechanism?
In most cases, it is not sufficient. Cortisol, GH, LH, FSH, sex hormones, and melatonin all show rhythmic or pulsatile secretion, so a single measurement is easily affected by sampling time. Mechanistic studies should set appropriate time points, cycle stages, or dynamic tests according to hormone characteristics.
6.3 How Should Total Hormones and Free Hormones Be Selected?
Total hormone levels include both protein-bound and free fractions, while free hormone levels are closer to the biologically active state. In studies of thyroid hormones, testosterone, cortisol, and related hormones, changes in binding proteins may affect interpretation of total hormone levels. Therefore, total or free hormone levels should be selected according to the research purpose.
6.4 What Are the Most Common Problems in Hormone Detection by ELISA?
Common problems include inappropriate sample dilution, mismatch with the standard curve range, matrix effects, interference from hemolysis or lipemia, antibody cross-reactivity, and excessive freeze-thaw cycles. For low-abundance hormone detection, sensitivity and sample handling should be given particular attention.
6.5 Does Increased Hormone Receptor Expression Indicate Enhanced Hormone Action?
Not necessarily. Increased receptor expression only indicates a change in potential responsiveness. The actual hormone effect also depends on ligand concentration, receptor activity, downstream signaling, coregulatory factors, receptor internalization, and target gene expression.
Endocrinology and hormone research should integrate hormone source, endocrine axis feedback, receptor expression, downstream signaling, and target organ function. Different hormones vary markedly in structural type, sampling time, detection method, and mechanism of action. Only by correlating hormone levels with functional endpoints can their roles in metabolism, reproduction, stress responses, bone metabolism, and hormone-dependent diseases be interpreted more accurately.
For more related articles, please see below:
[1] Endocrine system observation experiment
[2] Gonadotropins: Structural Features, Receptor Signaling, and Research and Application Frameworks
[3] Glucocorticoids: Scientific Overview and Key Application Considerations
危险品化学品经营许可证(带存储)